UNITY COMPLETE Trademark

Trademark Overview

On Wednesday, January 27, 2021, a trademark application was filed for UNITY COMPLETE with the United States Patent and Trademark Office. The USPTO has given the UNITY COMPLETE trademark a serial number of 90492072. The federal status of this trademark filing is REGISTERED as of Tuesday, August 30, 2022. This trademark is owned by BillionToOne, Inc.. The UNITY COMPLETE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Prenatal genetic testing to determine fetal risk of genetic disorders and medical complications for medical purposes
unity complete

General Information

Serial Number90492072
Word MarkUNITY COMPLETE
Filing DateWednesday, January 27, 2021
Status700 - REGISTERED
Status DateTuesday, August 30, 2022
Registration Number6834865
Registration DateTuesday, August 30, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 28, 2021

Trademark Statements

Goods and ServicesPrenatal genetic testing to determine fetal risk of genetic disorders and medical complications for medical purposes

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 28, 2021
Primary Code044
First Use Anywhere DateMonday, July 6, 2020
First Use In Commerce DateMonday, July 6, 2020

Trademark Owner History

Party NameBillionToOne, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025
Party NameBillionToOne, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025
Party NameBillionToOne, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events

Event DateEvent Description
Tuesday, August 30, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 30, 2022REGISTERED-PRINCIPAL REGISTER
Saturday, July 23, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, July 22, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, July 22, 2022EXAMINER'S AMENDMENT ENTERED
Friday, July 22, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 22, 2022EXAMINERS AMENDMENT E-MAILED
Friday, July 22, 2022SU-EXAMINER'S AMENDMENT WRITTEN
Thursday, June 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 2, 2022NON-FINAL ACTION E-MAILED
Thursday, June 2, 2022SU - NON-FINAL ACTION - WRITTEN
Thursday, May 12, 2022STATEMENT OF USE PROCESSING COMPLETE
Monday, May 2, 2022USE AMENDMENT FILED
Thursday, May 12, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 2, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, February 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 28, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 28, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 8, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 19, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 29, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 29, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 29, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 25, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 25, 2021NON-FINAL ACTION E-MAILED
Wednesday, August 25, 2021NON-FINAL ACTION WRITTEN
Saturday, August 14, 2021ASSIGNED TO EXAMINER
Thursday, June 24, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 24, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 24, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, January 30, 2021NEW APPLICATION ENTERED IN TRAM

Related Keywords

complete unity medical genetic complications purposes disorders fetal testing determine prenatal risk